BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.verified

BVXV

Price:

$1.36

Market Cap:

$16.05M

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Industry

Biotechnology

IPO Date

2015-05-12

Stock Exchange

NASDAQ

Ticker

BVXV

The PE Ratio as of November 2025 (TTM) for BiondVax Pharmaceuticals Ltd. (BVXV) is -0.58

According to BiondVax Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.58. This represents a change of 248.53% compared to the average of -0.17 of the last 4 quarters.

BiondVax Pharmaceuticals Ltd. (BVXV) Historical PE Ratio (quarterly & annually)

How has BVXV PE Ratio performed in the past?

The mean historical PE Ratio of BiondVax Pharmaceuticals Ltd. over the last ten years is -7.19. The current -0.58 PE Ratio has changed 705.42% with respect to the historical average. Over the past ten years (40 quarters), BVXV's PE Ratio was at its highest in in the September 2015 quarter at 90.59. The PE Ratio was at its lowest in in the March 2020 quarter at -18.87.

Quarterly (TTM)
Annual

Average

-7.19

Median

-4.34

Minimum

-50.66

Maximum

14.65

BiondVax Pharmaceuticals Ltd. (BVXV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BiondVax Pharmaceuticals Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.41%

Maximum Annual PE Ratio = 14.65

Minimum Annual Increase = -794.72%

Minimum Annual PE Ratio = -50.66

Quarterly (TTM)
Annual
YearPE RatioChange
2022-50.662.41%
2021-2.02-113.78%
202014.65-794.72%
2019-2.11-58.12%
2018-5.0380.72%
2017-2.79-40.86%
2016-4.7118.82%
2015-3.96-51.51%
2014-8.1816.01%
2013-7.057.98%

BiondVax Pharmaceuticals Ltd. (BVXV) Average PE Ratio

How has BVXV PE Ratio performed in the past?

The current PE Ratio of BiondVax Pharmaceuticals Ltd. (BVXV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.68

5-year avg

-9.03

10-year avg

-7.19

BiondVax Pharmaceuticals Ltd. (BVXV) PE Ratio vs. Peers

How is BVXV’s PE Ratio compared to its peers?

BiondVax Pharmaceuticals Ltd.’s PE Ratio is less than Neuphoria Therapeutics Inc. (-0.03), greater than Tectonic Therapeutic, Inc. (-5.89), less than Nabriva Therapeutics plc (-0.00), greater than Fresh Tracks Therapeutics, Inc. (-0.97), less than Gamida Cell Ltd. (-0.08), less than TNF Pharmaceuticals, Inc. (-0.12), less than Aptose Biosciences Inc. (-0.31), less than Hillstream BioPharma, Inc. (-0.05), less than Tricida, Inc. (-0.03), less than Altamira Therapeutics Ltd. (-0.02),

Build a custom stock screener for BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiondVax Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiondVax Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BiondVax Pharmaceuticals Ltd.'s PE Ratio?

How is the PE Ratio calculated for BiondVax Pharmaceuticals Ltd. (BVXV)?

What is the highest PE Ratio for BiondVax Pharmaceuticals Ltd. (BVXV)?

What is the 3-year average PE Ratio for BiondVax Pharmaceuticals Ltd. (BVXV)?

What is the 5-year average PE Ratio for BiondVax Pharmaceuticals Ltd. (BVXV)?

How does the current PE Ratio for BiondVax Pharmaceuticals Ltd. (BVXV) compare to its historical average?